Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MPL anticorps (AA 26-175)

MPL Reactivité: Humain ELISA, FACS Hôte: Souris Monoclonal 1D6B7 unconjugated
N° du produit ABIN5611182
  • Antigène Voir toutes MPL Anticorps
    MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))
    Épitope
    • 32
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 26-175
    Reactivité
    • 56
    • 26
    • 22
    • 1
    • 1
    Humain
    Hôte
    • 52
    • 7
    Souris
    Clonalité
    • 53
    • 6
    Monoclonal
    Conjugué
    • 20
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Cet anticorp MPL est non-conjugé
    Application
    • 38
    • 34
    • 14
    • 13
    • 13
    • 9
    • 5
    • 4
    • 4
    • 3
    • 2
    • 1
    ELISA, Flow Cytometry (FACS)
    Fonction
    CD110 Antibody
    Purification
    Purified antibody
    Immunogène
    Purified recombinant fragment of human CD110 (AA: 26-175) expressed in E. Coli.
    Clone
    1D6B7
    Isotype
    IgG2a
    Top Product
    Discover our top product MPL Anticorps primaire
  • Indications d'application

    ELISA: 1/10000

    FCM: 1/200 - 1/400

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified antibody in PBS with 0.05 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Antigène
    MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))
    Autre désignation
    CD110 (MPL Produits)
    Synonymes
    anticorps C-MPL, anticorps CD110, anticorps MPLV, anticorps THCYT2, anticorps TPOR, anticorps TPO-R, anticorps c-mpl, anticorps c-mpl-I, anticorps c-mpl-II, anticorps hlb219, anticorps MPL, anticorps mpll, anticorps tpor, anticorps tpor.b, anticorps MPL proto-oncogene, thrombopoietin receptor, anticorps myeloproliferative leukemia virus oncogene, anticorps MPL, anticorps Mpl, anticorps mpl
    Sujet

    Description: In 1990 an oncogene, v-mpl, was identified from the murine myeloproliferative leukemia virus that was capable of immortalizing bone marrow hematopoietic cells from different lineages. In 1992 the human homologue, named, c-mpl, was cloned. Sequence data revealed that c-mpl encoded a protein that was homologous with members of the hematopoietic receptor superfamily. Presence of anti-sense oligodeoxynucleotides of c-mpl inhibited megakaryocyte colony formation. The ligand for c-mpl, thrombopoietin, was cloned in 1994. Thrombopoietin was shown to be the major regulator of megakaryocytopoiesis and platelet formation. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs . TPO-R deficient mice were severely thrombocytopenic, emphasizing the important role of CD110 and thrombopoietin in megakaryocyte and platelet formation. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.

    Aliases: MPL, MPLV, TPOR, C-MPL, THCYT2

    Poids moléculaire
    71.2kDa
    ID gène
    4352
    HGNC
    4352
    UniProt
    P40238
    Pathways
    Signalistation JAK/STAT
Vous êtes ici:
Support technique